XML 38 R24.htm IDEA: XBRL DOCUMENT v3.6.0.2
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2016
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
NOTE 17 – EARNINGS PER SHARE
 
In accordance with ASC 260, outstanding instruments that contain rights to non-forfeitable dividends are considered participating securities. The Company is required to apply the two-class method or the treasury stock method of computing basic and diluted earnings per share when there are participating securities outstanding. The Company has determined that outstanding unvested restricted shares issued under the Manager Equity Plan are participating securities, and they are therefore included in the computation of basic and diluted earnings per share. The following tables provide additional disclosure regarding the computation for the years ended December 31, 2016, December 31, 2015 and December 31, 2014:
 
 
 
Year Ended December 31, 2016
 
Year Ended December 31, 2015
 
Year Ended December 31, 2014
 
Net income (loss)
 
 
 
 
$
(7,989,955)
 
 
 
 
$
450,479
 
 
 
 
$
3,313,785
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Less dividends paid:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock
 
$
29,898,918
 
 
 
 
$
19,874,663
 
 
 
 
$
18,229,875
 
 
 
 
Preferred stock
 
 
3,522,036
 
 
 
 
 
3,522,036
 
 
 
 
 
2,887,296
 
 
 
 
 
 
 
 
 
 
33,420,954
 
 
 
 
 
23,396,699
 
 
 
 
 
21,117,171
 
Undistributed earnings
 
 
 
 
$
(41,410,909)
 
 
 
 
$
(22,946,220)
 
 
 
 
$
(17,803,386)
 
 
 
 
Unvested Share-Based
 
 
 
 
Unvested Share-Based
 
 
 
 
Unvested Share-Based
 
 
 
 
 
 
Payment Awards
 
Common Stock
 
Payment Awards
 
Common Stock
 
Payment Awards
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distributed earnings
 
$
2.04
 
$
2.04
 
$
1.35
 
$
1.35
 
$
1.47
 
$
1.47
 
Undistributed earnings (deficit)
 
 
(2.83)
 
 
(2.83)
 
 
(1.56)
 
 
(1.56)
 
 
(1.44)
 
 
(1.44)
 
Total
 
$
(0.79)
 
$
(0.79)
 
$
(0.21)
 
$
(0.21)
 
$
0.03
 
$
0.03
 
 
No adjustment was required for the calculation of diluted earnings per share for the warrants described in Note 16 because the warrants’ exercise price is greater than the average market price of the common shares for the period, and thereby anti-dilutive.